Y-mabs hosting virtual research and development day

New york, dec. 06, 2021 (globe newswire) -- y-mabs therapeutics, inc. (the “company” or “y-mabs”) (nasdaq: ymab) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that it will host a virtual research and development day on wednesday, december 15, 2021 at 12pm eastern time.
YMAB Ratings Summary
YMAB Quant Ranking